More about
Sacituzumab Govitecan
News
December 20, 2022
3 min watch
Save
VIDEO: Sacituzumab govitecan effective regardless of Trop-2 expression level
News
October 26, 2022
7 min watch
Save
Important takeaways in breast cancer from ESMO 2022
News
October 12, 2022
1 min read
Save
FDA grants priority review to Trodelvy for pretreated metastatic breast cancer
News
July 07, 2022
2 min read
Save
Healio roundup: Top coverage in breast cancer from ASCO 2022
News
June 04, 2022
3 min read
Save
Sacituzumab govitecan significantly extends PFS in advanced breast cancer subset
News
March 08, 2022
2 min read
Save
Trodelvy prolongs PFS in metastatic breast cancer subset, topline data show
News
April 13, 2021
1 min read
Save
FDA approves Trodelvy for advanced urothelial cancer
News
April 07, 2021
1 min read
Save
FDA grants regular approval to Trodelvy for triple-negative breast cancer
News
December 11, 2020
4 min read
Save
Sacituzumab govitecan effective for triple-negative breast cancer regardless of biomarkers
News
October 27, 2020
9 min read
Save